Therapeutic Effect of Functional Buttermilk Supplemented with Red Beetroot Juice and Microencapsulated Probiotics against High-Fructose Corn Syrup Disorders in Rats

Fructose, a widely used sweetener in food and pharmaceutical industries, is linked to alterations in gut microbiota, bacterial metabolic changes, and chronic diseases. Therefore, functional buttermilk (FB) supplemented with 5% Red Beetroot Juice (RBJ), microencapsulated Lacticaseibacillus paracasei subsp. paracasei B-4564 and/or Bifidobacterium bifidum B-41410 were developed as a dietary intervention against High-Fructose Corn Syrup (HFCS) disorders in rats. Results revealed that RBJ exhibited potent antioxidant activity, 69.11% and 78.91% according to DPPH and ABTS assays, respectively. Higher survival rate and excellent stability of microencapsulated L. paracasei B-4564 and B. bifidum B-41410, either individually or in combination form, were observed during the storage period. Counts of microencapsulated probiotics increased significantly, L. paracasei B-4564 counts reached 9.60 and 9.75 log10 CFU/ml in T1 (FBRP) and T3 (FBRM), whereas B. bifidum B-41410 reached 9.46 and 9.55 log10 CFU/ml in T2 (FBRB) and T3 (FBRM), respectively. Additionally, after 5 months of in vivo study, biochemical parameters, fecal microbial counts, and histopathological examination of liver & intestinal tissues were evaluated. FBRM showed the most improvements in metabolic markers, including glucose, IR, liver functions, and lipid profiles, compared to the other groups. Significant reduction of rats’ fecal coliforms was found in contrast with the promotion of probiotic counts. Histopathological evaluation showed marked improvements to intestinal & liver tissues of rats receiving FBRM, followed by FBRP and FBRB, compared to the positive control. It could be recommended that daily administration of functional buttermilk supplemented with 5% RBJ and mixed microencapsulated L. paracasei B-4564 and B. bifidum B-41410 is an effective tool to overcome pathological features contributed to HFCS consumption.

Authors

Publication Details

Journal
Journal of Medical and Life Science
Published
2024-12-20
DOI
https://doi.org/10.21608/jmals.2024.425311
Primary Topic
Microbial Metabolites in Food Biotechnology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Therapeutic Effect of Functional Buttermilk Supplemented with Red Beetroot Juice and Microencapsulated Probiotics against High-Fructose Corn Syrup Disorders in Rats

Zakaria A. Mohamed, Eman S. El-Ashaal
Journal of Medical and Life Science
Microbial Metabolites in Food Biotechnology
article

Therapeutic Effect of Functional Buttermilk Supplemented with Red Beetroot Juice and Microencapsulated Probiotics against High-Fructose Corn Syrup Disorders in Rats

Zakaria A. Mohamed, Eman S. El-Ashaal
article en

Abstract

Fructose, a widely used sweetener in food and pharmaceutical industries, is linked to alterations in gut microbiota, bacterial metabolic changes, and chronic diseases. Therefore, functional buttermilk (FB) supplemented with 5% Red Beetroot Juice (RBJ), microencapsulated Lacticaseibacillus paracasei subsp. paracasei B-4564 and/or Bifidobacterium bifidum B-41410 were developed as a dietary intervention against High-Fructose Corn Syrup (HFCS) disorders in rats. Results revealed that RBJ exhibited potent antioxidant activity, 69.11% and 78.91% according to DPPH and ABTS assays, respectively. Higher survival rate and excellent stability of microencapsulated L. paracasei B-4564 and B. bifidum B-41410, either individually or in combination form, were observed during the storage period. Counts of microencapsulated probiotics increased significantly, L. paracasei B-4564 counts reached 9.60 and 9.75 log10 CFU/ml in T1 (FBRP) and T3 (FBRM), whereas B. bifidum B-41410 reached 9.46 and 9.55 log10 CFU/ml in T2 (FBRB) and T3 (FBRM), respectively. Additionally, after 5 months of in vivo study, biochemical parameters, fecal microbial counts, and histopathological examination of liver & intestinal tissues were evaluated. FBRM showed the most improvements in metabolic markers, including glucose, IR, liver functions, and lipid profiles, compared to the other groups. Significant reduction of rats’ fecal coliforms was found in contrast with the promotion of probiotic counts. Histopathological evaluation showed marked improvements to intestinal & liver tissues of rats receiving FBRM, followed by FBRP and FBRB, compared to the positive control. It could be recommended that daily administration of functional buttermilk supplemented with 5% RBJ and mixed microencapsulated L. paracasei B-4564 and B. bifidum B-41410 is an effective tool to overcome pathological features contributed to HFCS consumption.

Journal of Medical and Life ScienceVol. 6(4)
Zero hunger
Openalex Percentile: Top 67%
Microbial Metabolites in Food Biotechnology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Therapeutic Effect of Functional Buttermilk Supplemented with Red Beetroot Juice and Microencapsulated Probiotics against High-Fructose Corn Syrup Disorders in Rats — Zakaria A. Mohamed, Eman S. El-Ashaal · Journal of Medical and Life Science (2024) | TGRS Research Map | TGRS